Product logins

Find logins to all Clarivate products below.


Blog: Clinical trials

Here you will find relevant articles and insight into all Clarivate related products and news.

Tracking the mid-year momentum of the 2026 Drugs to Watch Tracking the mid-year momentum of the 2026 Drugs to Watch
Blog July 8, 2026
Tracking the mid-year momentum of the 2026 Drugs to Watch
Biopharma Biotech Clinical trials
Bringing oncology medicines to patients faster: How Clarivate R&D Consulting supports every step to approval Bringing oncology medicines to patients faster: How Clarivate R&D Consulting supports every step to approval
Blog June 24, 2026
Bringing oncology medicines to patients faster: How Clarivate R&D Consulting supports every step to approval
ADC Biopharma Biotech
Europe looks to shore up global competitiveness with the E.U. Biotech Act Europe looks to shore up global competitiveness with the E.U. Biotech Act
Blog June 22, 2026
Europe looks to shore up global competitiveness with the E.U. Biotech Act
Biopharma Biotech Business Development
Using AI-powered translational safety intelligence to anticipate drug safety issues earlier Using AI-powered translational safety intelligence to anticipate drug safety issues earlier
Blog June 22, 2026
Using AI-powered translational safety intelligence to anticipate drug safety issues earlier
Biopharma Biotech Clinical trials
De-risking next-generation bispecific antibodies: a target-centric approach to safety intelligence De-risking next-generation bispecific antibodies: a target-centric approach to safety intelligence
Blog June 9, 2026
De-risking next-generation bispecific antibodies: a target-centric approach to safety intelligence
Bispecific antibodies BsAb Clinical trials
The competitive signals hiding in plain sight for biopharma The competitive signals hiding in plain sight for biopharma
Blog May 8, 2026
The competitive signals hiding in plain sight for biopharma
Biopharma Business Development Clinical trials
Why ease of administration in new drugs sometimes draws a yawn from payers Why ease of administration in new drugs sometimes draws a yawn from payers
Blog February 26, 2026
Why ease of administration in new drugs sometimes draws a yawn from payers
Biopharma Biotech Clinical trials
The path forward: What comes after a CRL? The path forward: What comes after a CRL?
Blog February 24, 2026
The path forward: What comes after a CRL?
Biopharma Biotech Clinical trials

Clinical trials

Paradigm-changing primary Phase III data for malignant melanoma: What to expect from Relatlimab in combination with Opdivo Paradigm-changing primary Phase III data for malignant melanoma: What to expect from Relatlimab in combination with Opdivo
Blog June 23, 2021
Paradigm-changing primary Phase III data for malignant melanoma: What to expect from Relatlimab in combination with Opdivo
KEYNOTE-564 paves future role for immunotherapy in adjuvant renal cell carcinoma KEYNOTE-564 paves future role for immunotherapy in adjuvant renal cell carcinoma
Blog June 21, 2021
KEYNOTE-564 paves future role for immunotherapy in adjuvant renal cell carcinoma
Roche’s Tecentriq shows promise in resectable NSCLC: key takeaways for the market Roche’s Tecentriq shows promise in resectable NSCLC: key takeaways for the market
Blog June 18, 2021
Roche’s Tecentriq shows promise in resectable NSCLC: key takeaways for the market
Six oncology breakthroughs from Mainland China: Takeaways from ASCO 2021 Six oncology breakthroughs from Mainland China: Takeaways from ASCO 2021
Blog June 16, 2021
Six oncology breakthroughs from Mainland China: Takeaways from ASCO 2021
Top 10 oncology breakthroughs shared at ASCO 2021 Top 10 oncology breakthroughs shared at ASCO 2021
Blog June 8, 2021
Top 10 oncology breakthroughs shared at ASCO 2021
Medtech insights - Medtech portfolio strategy - ip litigation data Medtech insights - Medtech portfolio strategy - ip litigation data
Blog February 25, 2021
The unmet need for precision medicine in Lyme disease
Regulatory response to the COVID-19 pandemic: Careful planning to minimize disruptions Regulatory response to the COVID-19 pandemic: Careful planning to minimize disruptions
Blog January 29, 2021
Regulatory response to the COVID-19 pandemic: Careful planning to minimize disruptions
Delays in clinical trials present opportunities for pharma companies to evolve Delays in clinical trials present opportunities for pharma companies to evolve
Blog November 25, 2020
Delays in clinical trials present opportunities for pharma companies to evolve
Biomarkers have several key roles in clinical trials and precision medicine Biomarkers have several key roles in clinical trials and precision medicine
Blog November 2, 2020
Biomarkers have several key roles in clinical trials and precision medicine
Clarivate Reports Fourth Quarter and Full Year 2021 Results Clarivate Reports Fourth Quarter and Full Year 2021 Results
Blog October 22, 2020
What drives the therapy selection test market?